The fact that IL-6 and IL-8 represent rather unspecific inflammatory cytokines, which most likely reflect high tumor regeneration and proliferation capacity, could imply that these markers are rather method specific for TACE therapy and less tumor specific. The gene discussed is IL6; the disease is neoplasm.